Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $6.2700 (-7.93%) ($6.0000 - $6.6700) on Thu. Jun. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 35 | Latest Price | $6.2700(-7.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.6% a day on average for past five trading days. | Weekly Trend | ANPC declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) PCY(10%) LIT(9%) HYG(8%) IPO(8%) | Factors Impacting ANPC price | ANPC will decline at least -1.98% in a week (0% probabilities). SHY(-18%) XBI(-8%) IBB(-8%) XLU(-6%) XLP(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | 0 () | Intraday Trend | -6% | | | |
|
1 - 5 Day Possible Target | $-2.58(-141.15%) | Resistance Level | $7.16 | 5 Day Moving Average | $6.91(-9.26%) | 10 Day Moving Average | $6.95(-9.78%) | 20 Day Moving Average | $7.16(-12.43%) | To recent high | -26.1% | To recent low | 0% | Market Cap | $54m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |